To understand B7-H3 (CD267) expression in the broader immune–oncology context, we compared B7-H3 expression levels to the inferred levels of 26 tumour-infiltrated immune cell types or states in samples across 34 cancer types from The Cancer Genome Atlas (TCGA). This evidence concerns the gene CD276 and cancer.